Abstract
The potential of modern somatostatin analogues in treatment of a variety of malignancies still remains to be established. However, much experimental and clinical evidence suggests that modern somatostatin analogues could provide a useful palliative form of treatment for some tumors. Somatostatin analogues could be also considered for use as adjuncts to therapy with LH-RH analogues in breast cancer and prostate cancer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 6977-6985 |
| Number of pages | 9 |
| Journal | Cancer Research |
| Volume | 48 |
| State | Published - 2016 |
| Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Cancer Research
